XENE Latest Headlines

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Veeva Systems (VEEV) and Liquidia Technologies (LQDA)

at www.tipranks.com (Wed, 11-Nov 5:50 AM)

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), ArriVent BioPharma, Inc. (AVBP) and PepGen Inc. (PEPG)

at www.tipranks.com (Tue, 10-Nov 11:01 AM)

Xenon: Undervalued Ahead of Azetukalner’s FDA Decision, with Pipeline and Liquidity Supporting Upside

at www.tipranks.com (Tue, 10-Nov 8:05 AM)

Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Xenon (XENE) and Perspective Therapeutics (CATX)

at www.tipranks.com (Tue, 10-Nov 8:01 AM)

Needham Keeps Their Buy Rating on Xenon (XENE)

at www.tipranks.com (Tue, 10-Nov 7:36 AM)

Analyst Reiterates Buy on Azetukalner’s Clinical Promise, Maintains $74 Price Target

at www.tipranks.com (Tue, 10-Nov 6:55 AM)

Analysts Are Bullish on These Healthcare Stocks: Xenon (XENE), Ocular Therapeutix (OCUL)

at www.tipranks.com (Tue, 10-Nov 5:40 AM)

Xenon Reports Third-Quarter 2026 Results and Business Update

at www.tipranks.com (Mon, 9-Nov 5:28 PM)

Xenon Pharma GAAP EPS of -$1.11 beats by $0.03

at seekingalpha.com (Mon, 9-Nov 4:31 PM)

Xenon’s Phase 1 readouts put a “>75% receptor occupancy” bar at the center of its non-opioid acute pain push

Market Chameleon (Thu, 29-Oct 9:20 AM)

Xenon files azetukalner NDA for focal seizures as psychiatry enrollment is temporarily paused

Market Chameleon (Fri, 18-Sep 9:54 AM)